Date: 2011-11-22
Type of information:
Compound: Additional drug product
Company: OctoPlus (The Netherlands) undisclosed partner
Therapeutic area:
Type agreement: Manufacturing
Production
Action mechanism:
Disease: undisclosed
Details: OctoPlus has received a commitment from an existing client for OctoPlus to manufacture additional drug product for this client. The contract value will make a material contribution to OctoPlus' annual revenues in 2012.
Financial terms: Further financial details are not disclosed.
Latest news:
